EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HBV capsid assembly modulators differentially modulate the assembly of wild-type and drug-resistant core protein chimeric nucleocapsids and empty capsids

Hui Liu, Hemraj Rimal, Jun Lyu, Liangxian Shen, Qiong Zhao, Jinhong Chang, Ju-Tao Guo iD

PLOS Pathogens · 05.08.2025 · 21 (8) · e1013391

DOI: 10.1371/journal.ppat.1013391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 05.08.2025. Verfasst von Hui Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Hepatitis B virus, Virus Assembly, Capsid, Nucleocapsid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peer Reviewed Medical Research Program, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple capsid assembly modulators (CAMs) are in clinical development for the treatment of chronic hepatitis B. The emergence of CAM-resistant HBV has resulted in the failure of CAM antiviral therapy in recent clinical trials. Because wild-type (WT) and CAM-resistant core protein (Cp) can co-assemble to form chimeric capsids, it is important to understand how CAMs modulate the assembly and disassembly of chimeric capsids and how CAM-resistant HBV variants emerge under CAM antiviral therapy. In addressing these questions, we found that in human hepatoma cells co-transfected with a serial molar ratio of WT and mutant HBV replicons expressing CAM-resistant Cp, expression of as few as 10% WT Cp conferred inhibition of nucleocapsid assembly by CAMs. However, 50% Cp with T33N substitution conferred complete resistance to the assembly of chimeric empty capsids induced by AB-506 but remained sensitive to GLS4, as determined in an in vitro capsid assembly assay and in transfected hepatoma cells. Moreover, the existence of approximately 50% WT Cp in chimeric nucleocapsids is required for CAMs to induce the disassembly of mature nucleocapsids and inhibit the infection of hepatocytes by HBV virions with chimeric nucleocapsids. Our results thus suggest that although disruption of nucleocapsid assembly requires only small numbers of CAM binding pockets at Cp dimer-dimer interfaces to be engaged, induction of mature nucleocapsid disassembly requires much larger numbers of CAM binding pockets to be occupied. The strong WT Cp dominance in CAM suppression of nucleocapsid assembly may slow down the emergence of CAM-resistant HBV variants under CAM therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusVirus AssemblyCapsidNucleocapsidDrug Resistance, ViralViral Core ProteinsHumansAntiviral AgentsCapsid ProteinsCell Line, Tumor

Substanzen

Antiviral AgentsViral Core ProteinsCapsid Proteins

Autor:innen und Institutionen

  • Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.

ORCID-Profile: Ju-Tao Guo

Förderung

  • Peer Reviewed Medical Research Program
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Liu, H., Rimal, H., Lyu, J., Shen, L., Zhao, Q., Chang, J., & Guo, J. T. (2025). HBV capsid assembly modulators differentially modulate the assembly of wild-type and drug-resistant core protein chimeric nucleocapsids and empty capsids. PLOS Pathogens, 21(8), e1013391. https://doi.org/10.1371/journal.ppat.1013391

Vancouver

Liu H, Rimal H, Lyu J, Shen L, Zhao Q, Chang J, et al. HBV capsid assembly modulators differentially modulate the assembly of wild-type and drug-resistant core protein chimeric nucleocapsids and empty capsids. PLOS Pathogens. 2025;21(8):e1013391. doi:10.1371/journal.ppat.1013391

BibTeX
@article{Liu2025,
  author = {Liu, Hui and Rimal, Hemraj and Lyu, Jun and Shen, Liangxian and Zhao, Qiong and Chang, Jinhong and Guo, Ju-Tao},
  title = {HBV capsid assembly modulators differentially modulate the assembly of wild-type and drug-resistant core protein chimeric nucleocapsids and empty capsids},
  journal = {PLOS Pathogens},
  year = {2025},
  volume = {21},
  number = {8},
  pages = {e1013391},
  doi = {10.1371/journal.ppat.1013391}
}
Kostenlos starten →